{
  "bio": [
    "Thomas Struengmann and twin brother Andreas were early backers of German firm BioNTech, which partnered with Pfizer to make a vaccine for Covid-19.",
    "The brothers cofounded generic drugmaker Hexal in 1986 and sold it to Novartis in 2005 for some $7 billion.",
    "The brothers invest in biotech, pharma, life sciences and healthcare companies through their Zug, Switzerland-based investment firm, Santo Holding.",
    "In 2008, they established a neuroscience research center in Frankfurt named after their father, Ernst Struengmann."
  ],
  "about": [
    "After obtaining a business degree from the University of Augsburg, Thomas worked as a marketing manager for Schering-Plough.",
    "Like his brother, an identical twin, he is said to be an accomplished golfer and likes to ski. He reportedly collects modern art and Swiss watches."
  ]
}